✦ LIBER ✦

Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

✍ Scribed by Samuel Cos; Alicia González; Carlos Martínez-Campa; Maria Dolores Mediavilla; Carolina Alonso-González; Emilio J. Sánchez-Barceló

Book ID: 113524348
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 438 KB
Volume: 30
Category: Article
ISSN: 0361-090X
DOI: 10.1016/j.cdp.2006.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective estrogen enzyme modulator acti

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

✍ A. Gonzalez; S. Cos; C. Martinez-Campa; C. Alonso-Gonzalez; S. Sanchez-Mateos; M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

The relationships between snail1 and est

The relationships between snail1 and estrogen receptor signaling in breast cancer cells

✍ Alexander M. Scherbakov; Olga E. Andreeva; Valentina A. Shatskaya; Mikhail A. Kr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Bidirectional interactions between the e

Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

Proteasome inhibition represses ERα gene

Proteasome inhibition represses ERα gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer

✍ Ellison-Zelski, S J; Casa, A J; Lee, A V; Alarid, E T; Powers, G L 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 639 KB

Breast cancer cells can switch between e

Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

✍ Katrine Sonne-Hansen; Ida C. Norrie; Kristina B. Emdal; Rikke V. Benjaminsen; Th 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 521 KB

Stimulation of the bradykinin B1receptor

Stimulation of the bradykinin B1receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway

✍ Luis Molina; Carola E. Matus; Angel Astroza; Francisca Pavicic; Eugenio Tapia; C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 671 KB